Processa Pharmaceuticals, Inc. (PCSA) Financials
PCSA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 4.5 million | 2.0 million |
| Dec. 31, 2025 | 7.8 million | 2.2 million |
| Sept. 30, 2025 | 7.6 million | 1.8 million |
| June 30, 2025 | 8.2 million | 2.1 million |
PCSA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -3.6 million | 95963 |
| Dec. 31, 2025 | -2.9 million | 351252 |
| Sept. 30, 2025 | -3.5 million | 75336 |
| June 30, 2025 | -2.3 million | 430962 |
PCSA Net Income
No data available :(
PCSA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 1.7 million | - | - |
| Dec. 31, 2025 | 5.5 million | - | - |
| Sept. 30, 2025 | 6.3 million | - | - |
| June 30, 2025 | 6.9 million | - | 25584 |
PCSA Shares Outstanding
PCSA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 1.8 million | 1.5 million | -301 |
| Dec. 31, 2025 | 2 | 2.1 million | 1.6 million | - |
| Sept. 30, 2025 | - | 1.7 million | 1.8 million | - |
| June 30, 2025 | - | 2.4 million | 1.5 million | - |
PCSA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 301 |
| Dec. 31, 2025 | - | 301 |
| Sept. 30, 2025 | - | 301 |
| June 30, 2025 | - | 301 |
PCSA
Price: $2.12
52 week price:
Earnings Per Share: -4.07 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 125600
Market Capitalization: 6.3 million